P
Protagonist Therapeutics D
D
PTGX
45.730
USD
-0.22
(-0.48%)
مغلق
حجم التداول
18,205
الربح لكل سهم
-0
العائد الربحي
-
P/E
59
حجم السوق
2,834,434,802
الأخبار المقالات
العنوان: Protagonist Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.